Upcoming Biotech Catalyst For February 2018


31-Jan-2018 16:32 PM



    Biotechnology sector has a great month in January 2018 with two ETFs: iShares Nasdaq Biotechnology EFT (IBB:NASDAQ) up +6.94%  and Spdr S&P Biotech Etf (XBI:NASDAQ) up +10.9%. There are three notable buyout in January, they are:  Bioverativ Inc (BIVV:NASDAQ), Juno Therapeutics Inc (JUNO:NASDAQ), and Cascadian Therapeutics Inc (CASC:NASDAQ). As the month ends, we look forward for future biotech stock to invest and trade. Here are the list for upcoming biotech stocks to watch.

Full list of upcoming biotech data catalyst

For The Prescription Drug User Fee Act (PDUFA) event, check this calendar out

February potential catalyst for PDUFA and data readouts:

   It's free to sign on the site and lets us know if there are more upcoming biotech data. Best of luck biotech enthusiast.

Contact us:

Twitter: @BiotechMoney18 and @TradersFish






01-Feb-2018 05:51 AM

The next catalyst about AVEO is not about that TIVO-3, but a trial named TiNiVo which is a Phase 2 trial targeting RCC



01-Feb-2018 09:15 AM

To the user @Jian5702 they do have phase 3, TIVO-3 read out in Q1 2018. Here is the company link source. Nov 7, 2017 3Q press release

Add Your Comment

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.